Investors sold shares of Colgate-Palmolive (NYSE:CL) on strength during trading on Friday. $48.43 million flowed into the stock on the tick-up and $78.29 million flowed out of the stock on the tick-down, for a money net flow of $29.86 million out of the stock. Of all stocks tracked, Colgate-Palmolive had the 0th highest net out-flow for the day. Colgate-Palmolive traded up $1.26 for the day and closed at $63.75
A number of analysts have commented on the stock. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $72.00 price target on shares of Colgate-Palmolive in a research report on Thursday. Argus raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Friday. They noted that the move was a valuation call. Citigroup cut their price objective on shares of Colgate-Palmolive from $80.00 to $73.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 1st. Barclays set a $70.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Monday, April 30th. Finally, ValuEngine cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company. Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $76.38.
The company has a current ratio of 1.08, a quick ratio of 0.75 and a debt-to-equity ratio of 64.85. The stock has a market capitalization of $55.61 billion, a PE ratio of 22.21, a PEG ratio of 2.52 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, April 27th. The company reported $0.74 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 13.30% and a return on equity of 1,486.69%. The company had revenue of $4 billion for the quarter, compared to analyst estimates of $4.01 billion. During the same quarter in the prior year, the business posted $0.67 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. equities analysts anticipate that Colgate-Palmolive will post 3.17 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 15th. Investors of record on Friday, April 20th were issued a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.64%. The ex-dividend date was Thursday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s dividend payout ratio is currently 58.54%.
In related news, insider Daniel B. Marsili sold 19,500 shares of the company’s stock in a transaction dated Tuesday, May 15th. The shares were sold at an average price of $61.69, for a total value of $1,202,955.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Vice Chairman Franck J. Moison sold 80,000 shares of the company’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $61.75, for a total transaction of $4,940,000.00. The disclosure for this sale can be found here. Insiders sold a total of 142,079 shares of company stock worth $8,981,683 in the last 90 days. 1.02% of the stock is currently owned by company insiders.
Large investors have recently bought and sold shares of the business. National Pension Service increased its stake in shares of Colgate-Palmolive by 4.2% during the 4th quarter. National Pension Service now owns 708,932 shares of the company’s stock worth $53,489,000 after purchasing an additional 28,585 shares during the last quarter. Community Bank & Trust Waco Texas purchased a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $202,000. Sicart Associates LLC increased its stake in shares of Colgate-Palmolive by 96.8% during the 4th quarter. Sicart Associates LLC now owns 12,200 shares of the company’s stock worth $920,000 after purchasing an additional 6,000 shares during the last quarter. Gateway Investment Advisers LLC increased its stake in shares of Colgate-Palmolive by 9.0% during the 4th quarter. Gateway Investment Advisers LLC now owns 696,674 shares of the company’s stock worth $52,564,000 after purchasing an additional 57,678 shares during the last quarter. Finally, Marathon Asset Management LLP increased its stake in shares of Colgate-Palmolive by 3.0% during the 4th quarter. Marathon Asset Management LLP now owns 1,507,796 shares of the company’s stock worth $113,773,000 after purchasing an additional 44,108 shares during the last quarter. Hedge funds and other institutional investors own 73.30% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.